Latest Commercial Rollout News

Neuren Pharmaceuticals reported an 8% rise in H1 2026 revenues driven by DAYBUE royalties, but profit fell 68% due to ramped-up R&D. The company declared its first ever dividend, signalling confidence amid ongoing clinical and regulatory milestones.

Janison Education Group has landed a landmark subcontract with NFER to deliver Scotland's national standardised assessments, marking its first UK government contract and a strategic expansion beyond ANZ.

Sparc Technologies launches a $2.5 million capital raise via a Share Purchase Plan and placement to fast-track commercial rollout of its graphene additive ecosparc® and support green hydrogen scale-up.

Memphasys has cleared a key regulatory hurdle in Vietnam for its Felix™ System, prompting a significant first commercial cartridge order and marking early clinical success in a fast-growing fertility market.

ImpediMed has secured FDA 510(k) clearance for its SOZO Digital Health Platform to assess sarcopenia risk, marking it as the only FDA-cleared bioimpedance spectroscopy solution for this clinical application. This clearance enables clinicians to non-invasively monitor muscle loss in cancer and chronic disease patients, potentially improving treatment outcomes.

NAOS Ex-50 Opportunities Company Limited reported a $3.09 million after-tax loss for FY26 but raised its dividend by 5% and continued an active share buyback, reflecting confidence despite portfolio underperformance.

Proteomics International has achieved a key patent acceptance in Australia for its PromarkerEndo blood test, reinforcing its intellectual property portfolio and commercialisation strategy in a major healthcare market.

Klevo Rewards extended its financial services footprint with two acquisitions and proposed a 10:1 share consolidation, while Fly Wallet posted $19 million revenue from an early-stage stablecoin trial in July 2026.

EBR Systems marked a commercial milestone with over 100 WiSE CRT implants and secured purchasing agreements with three major US healthcare networks. The company is progressing toward Medicare coverage and scaling manufacturing, supported by a near-complete A$150 million capital raise.

Sprintex has inked a co-development deal with Jiangsu Bosiwei to supply its 30kW MVR compressors for a major retrofit at Hebei Yufeng Group, marking its strategic entry into China’s booming industrial vapor compression market.

ReNerve Limited has gained marketing approval for its flagship NervAlign Nerve Cuff in India, marking a critical milestone in its global expansion and enabling commercial rollout in one of the world's largest nerve repair markets.

ClearVue Technologies has secured Clean Energy Council approval for its ClearVue-Helios rooftop solar panels, enabling government subsidies and grid connection in Australia. This certification coincides with expanded commercial solar incentives, potentially lowering costs for customers.